Stephen C. Glover

Insider Reports History

Location
Weston, FL
Signature
/s/ Peter Wolfe as Attorney-in-Fact for Stephen C. Glover pursuant to Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen C. Glover:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma Inc. Director Ordinary Shares 85,000 $785,800 $9.24 07 Jun 2023 Direct
PDS Biotechnology Corp Director Common Stock 78,851 $130,893 $1.66 28 Feb 2025 Direct
Ambrx Biopharma, Inc. Director Restricted Stock Units 0 $0 $9.82 07 Mar 2024 Direct
ZyVersa Therapeutics, Inc. Chief Executive Officer, Director Stock Options 136,900 11 Jul 2025 Direct
PDS Biotechnology Corp Director Employee Stock Option (Right to Buy) 22,700 11 Jun 2025 Direct
Ambrx Biopharma Inc. Director Stock Option (right to buy) 17,500 18 May 2023 Direct
PDS Biotechnology Corp Director Common Warrant 15,061 28 Feb 2025 Direct
PDS Biotechnology Corp Director Employee Stock Option (Right to Buy) 9,000 24 Jun 2024 Direct
ZyVersa Therapeutics, Inc. Chief Executive Officer, Director Stock Options 1,627 24 May 2023 Direct
Ambrx Biopharma, Inc. Director Option to Purchase Common Stock 0 07 Mar 2024 Direct

Insider Reports Filed by Stephen C. Glover

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZVSA ZyVersa Therapeutics, Inc. 11 Jul 2025 1 $0 4 Chief Executive Officer, Director 15 Jul 2025, 16:22
PDSB PDS Biotechnology Corp 11 Jun 2025 1 $0 4 Director 11 Jun 2025, 18:00
PDSB PDS Biotechnology Corp 28 Feb 2025 2 +$25,001 4 Director 03 Mar 2025, 16:45
PDSB PDS Biotechnology Corp 24 Jun 2024 1 $0 4 Director 25 Jun 2024, 16:05
AMAM Ambrx Biopharma, Inc. 07 Mar 2024 4 $0 4 Director 07 Mar 2024, 17:45
PDSB PDS Biotechnology Corp 14 Jul 2023 1 $0 4 Director 17 Jul 2023, 17:26
ZVSA ZyVersa Therapeutics, Inc. 24 May 2023 1 $0 4 Chief Executive Officer, Director 18 Jul 2024, 21:35
AMAM Ambrx Biopharma Inc. 18 May 2023 3 $0 4 Director 09 Jun 2023, 16:17
AMAM Ambrx Biopharma Inc. 18 May 2023 1 $0 4 Director 26 May 2023, 20:20
AMAM Ambrx Biopharma Inc. 18 May 2023 0 $0 3 Director 19 May 2023, 16:05
ZVSA ZyVersa Therapeutics, Inc. 12 Dec 2022 14 $0 4 Chief Executive Officer, Director 14 Dec 2022, 18:24
ZVSA ZyVersa Therapeutics, Inc. 12 Dec 2022 0 $0 3 Chief Executive Officer, Director 13 Dec 2022, 09:49
PDSB PDS Biotechnology Corp 28 Jun 2022 1 $0 4 Director 29 Jun 2022, 16:16
PDSB PDS Biotechnology Corp 15 Jun 2021 2 +$49,997 4 Director 17 Jun 2021, 19:15